SCHEMBL2258197

SCHEMBL2258197

COc1ccc(-c2cn(-c3ccc(C(F)(F)F)cc3F)nn2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 2/20 0.57
▸ HSP90AA1 P07900 2/20 0.55
▸ HSP90AB1 P08238 2/20 0.55
▸ MGAM O43451 2/20 0.48
▸ GAA P10253 2/20 0.48
▸ SI P14410 2/20 0.48
▸ MGAM2 Q2M2H8 2/20 0.48
▸ PTGS2 P35354 4/20 0.46
▸ PTGS1 P23219 1/20 0.46
▸ CYP1B1 Q16678 1/20 0.45
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA5A P35218 1/20 0.45
▸ CA5B Q9Y2D0 1/20 0.45
▸ STS P08842 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18328168 0.88 CA12 (0.47) ABCG2HSP90AA1HSP90AB1PTGS2CA1
SCHEMBL20249064 0.86 PTGS2 (0.47) ABCG2MGAMGAASIMGAM2
SCHEMBL27792726 0.84 PTGS2 (0.44) ABCG2PTGS2PTGS1STSCA12
SCHEMBL2262206 0.84 P2RY14 (0.52) ABCG2HSP90AA1HSP90AB1PTGS2KDM4E
SCHEMBL27813952 0.84 P2RY14 (0.54) ABCG2PTGS2STSCA12CA9
SCHEMBL23557816 0.83 STS (0.66) ABCG2PTGS2CA1CA2CA5A
SCHEMBL13315795 0.76 ABCG2 (0.52) ABCG2HSP90AA1HSP90AB1MGAMGAA
SCHEMBL549105 0.75 POLB (0.54) ABCG2HSP90AA1HSP90AB1PTGS2KDM4E
SCHEMBL1550424 0.75 RAB9A (0.53) ABCG2HSP90AA1HSP90AB1PTGS2PTGS1
SCHEMBL18328169 0.73 ABCG2 (0.42) ABCG2HSP90AA1HSP90AB1MGAMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201656-A1 NOVEL DIPHENYL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS NEUROSEARCH A/S (DK) 2011-08-18 — — US claimed
US-20110201656-A1 NOVEL DIPHENYL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS NEUROSEARCH A/S (DK) 2011-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201656-A1 NOVEL DIPHENYL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA3, CHRNB3, CHRNA5 ABCG2 3211/4885HSP90AA1 4117/4885HSP90AB1 4053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback